A crisis comes in all forms. Some are company-specific, while others are industry-specific. They can also be specific to geographical location or global. Regardless of the type of crisis, the Chief Financial Officer or CFO plays an important role, if not the most crucial role during these times.

Read More

In Part I of our Startup Tax Issues series, we discussed how to avoid penalties with valuations. But what about issues related to 83(b) elections? Startup founders or other service providers receiving restricted stock should strongly consider making an 83(b) election in the year the restricted stock is granted.

Read More

Filing taxes can be intimidating, but it’s as inevitable as death. Tax rules are complicated, subject to change, and frequently poorly written. Early-stage startup taxation is a relatively limited field and this is good news for founders. Four topics makeup about 60-80% of founder tax issues. In this two-part blog series, we will address common…

Read More

In 2013, there was a slowdown in clinical trials due to clinical trial litigation. Afterward, India experienced an upward trend. Read more about the history of clinical trials and the risks in part I and part II of this series. There are several reasons behind the positive growth in clinical phase 1 and phase 2…

Read More

Although India has made adjustments to match global clinical trial regulation standards, the country still has some work to do. Several grey areas still need to be addressed. In some cases, regulatory authorities are the solution. Other issues require industry practices derived from trial and error. This unfortunately raises significant risk and liability questions. Clinical…

Read More

The emergence of initial coin offerings revolutionized public companies and fundraising. With very few SEC regulations, companies were allowed to raise millions of dollars that weren’t scrutinized by red tape. Companies who were able to sell their vision and coin to the public earned big. However, ICOs are now governed by regulatory bodies that provide…

Read More

The Indian pharmaceutical market is worthy of attention. It’s the third-largest globally by volume and 13th largest by value. The country is also the biggest producer of generic drugs, accounting for 20% of global exports in volume. In 2017, the Drug Controller General of India announced a new clinical trials policy. This policy provided greater…

Read More

With every registration form, online purchase, and new account you create, you share sensitive personal information. Email addresses, phone numbers, banking information, passwords, and the list goes on. Companies and online marketers claim that collecting this information is only to provide you with a better browsing experience. But how can you be sure that your…

Read More

The Indian market is on the rise. Investment opportunities are emerging within various industries and sectors. Being well-versed in the growing trends, business leaders are capitalizing on new technologies and tax rates. This may result in a substantial return on investment.   Industrial Growth Trends in the Indian Market Arguably, three interrelated factors position India as…

Read More